데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
56038-13-2OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1ClBAQAVOSOZGMPRM-QBMZZYIRSA-NSucralose is a disaccharide derivative consisting of 4-chloro-4-deoxy-alpha-D-galactopyranose and 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranose units linked by a glycosidic bond. It has a role as a xenobiotic, a sweetening agent and an environmental contaminant. It is an organochlorine compound and a disaccharide derivative.
56038-13-2DTXSID1040245CHEMBL3185084CHEBI:32159NUTRITIVE SWEETENER -> FDA Substance added to food
Food
White to off white, crystalline powder
Anhydrous crystalline form: orthorhombic, needle-like crystals
Syrup
Freely soluble in water, methanol and ethanol; Slightly soluble in ethyl acetate
Freely soluble in methanol, alcohol; slightly soluble in ethyl acetate
130 °C
MP: 36.5 °C /Sucralose pentahydrate/
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 100% (309 of 309) of all reports.
Not Classified
Aggregated GHS information provided per 309 reports by companies from 2 notifications to the ECHA C&L Inventory.
Chemical: .alpha.-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranosyl 4-chloro-4-deoxy-
Regulation (EC) No 178/2002 (amended)
.alpha.-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranosyl 4-chloro-4-deoxy- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of .alpha.-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-.beta.-D-fructofuranosyl 4-chloro-4-deoxy- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Status: Active Update: 20-10-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/25256
Sucralose: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Sucralose is a food additive permitted for direct addition to food for human consumption, as long as 1) the quantity of the substance added to food does not exceed the amount reasonably required to accomplish its intended physical, nutritive, or other technical effect in food, and 2) any substance intended for use in or on food is of appropriate food grade and is prepared and handled as a food ingredient.
Positive allosteric modulators of the human sweet taste receptor ...developed as a new way of reducing dietary sugar intake .../can be used as/ ...valuable tool molecules to study the general mechanism of positive allosteric modulations of T1R taste receptors. Using chimeric receptors, mutagenesis, and molecular modeling, .../the study/ reveal how ...sweet enhancers follow a similar mechanism as the natural umami taste enhancer molecules. Whereas the sweeteners bind to the hinge region and induce the closure of the Venus flytrap domain of T1R2, the enhancers bind close to the opening and further stabilize the closed and active conformation of the receptor.
Three male subjects given a single oral dose (1.11 mg/kg b.w., 0.3 uCi/kg) of trichlorogalactosucrose uniformly labelled with carbon-14 excreted an average of 13.5% of the radioactivity in urine and 82.1% in feces in 5 days. ... Maximum levels of radioactivity in the blood occurred within 2-3 hours and in two of the subjects declined with a half-life of approximately 2.5 hours.
Following a single oral dose of (14)C-sucralose (1mg/kg, 100 microCi) to eight male subjects, a mean of 14.5% (range 8.9 to 21.8%) of the radioactivity was excreted in urine and 78.3% (range 69.4 to 89.6%) in the feces, within 5 days. The total recovery of radioactivity averaged 92.8%. Plasma concentrations of radioactivity were maximal at about 2 hours after dosing. The mean residence time (MRT) for sucralose was 18.8 hr, while the effective half-life for the decline of plasma radioactivity was 13 hr. Two volunteers given a higher oral dose (10 mg/kg, 22.7 uCi) excreted a mean of 11.2% (9.6 and 12.7%) of the radioactivity in urine, and 85.5% (84.1 and 86.8%) in feces over 5 days. The total recovery of radioactivity was 96.7%. The radiolabelled material present in feces was essentially unchanged sucralose. Sucralose was the principal component in the urine together with two more polar components which accounted for only 2.6% of the administered dose (range 1.5 to 5.1% of dose); both metabolites possessed characteristics of glucuronide conjugates of sucralose.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
[α]D/20 + 84,0° to + 87,5° calculated on the anhydrous basis (10 % w/v solution)
Specific optical rotation: +68.3 deg at 25 deC/D (c = 1.1. in ethanol)
White to off-white, practically odourless, crystalline powder.
Syrup; Anhydrous form is solid; [Merck Index] White to off-white solid; [HSDB] White powder; [Sigma-Aldrich MSDS]
174.5 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID1040245]
178.62 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
177.2 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
179.16 Ų [M-H]-
SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal and plant life; and conformance with environmental and public health regulations.
SRP: In bulk storage or manufacturing situations where combustible dusts can collect in sufficient concentrations to give rise to an explosion/deflagration, reasonable precautions shall be taken to reduce or eliminate the hazard. Efforts shall be made to control or eliminate the five elements necessary to initiate a dust explosion. These include combustible dust (fuel), ignition source (heat), oxygen in air (oxidizer), and dispersion of dust particles in sufficient quantity and concentration as well as confinement of the dust cloud. General guidance in these efforts can be found in OSHA's "Combustible Dust in Industry; Preventing and Mitigating the Effects of Fire and Explosions", which list measures to control dusts, eliminate ignition sources, and limit the effects of explosions.
/The study/...investigated the ability of zinc sulfate (5, 25, 50 mM) to inhibit the sweetness of 12 chemically diverse sweeteners, which were all intensity matched to 300 mM sucrose [800 mM glucose, 475 mM fructose, 3.25 mM aspartame, 3.5 mM saccharin, 12 mM sodium cyclamate, 14 mM acesulfame-K, 1.04 M sorbitol, 0.629 mM sucralose, 0.375 mM neohesperidin dihydrochalcone (NHDC), 1.5 mM stevioside and 0.0163 mM thaumatin]. Zinc sulfate inhibited the sweetness of most compounds in a concentration dependent manner, peaking with 80% inhibition by 50 mM. Curiously, zinc sulfate never inhibited the sweetness of Na-cyclamate. This suggests that Na-cyclamate may access a sweet taste mechanism that is different from the other sweeteners, which were inhibited uniformly (except thaumatin) at every concentration of zinc sulfate.
TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that sucralose is expected to have very high mobility in soil(SRC). Volatilization of sucralose from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 4.0X10-19 atm-cu m/mole(SRC), using a fragment constant estimation method(3). Sucralose is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.2X10-14 mm Hg at 25 °C(SRC), determined from a fragment constant method(4). Mineralization of 14CO2-labeled sucralose ranged from 32.6 to 60.4% over 20 to 101 days using four loam soils(5), indicating that biodegradation may be an important environmental fate process in soil(SRC). However, in an anaerobic environment, sucralose was not mineralized in soil(5).
AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that sucralose is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 4.0X10-19 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). According to a classification scheme(5), an estimated BCF of three(SRC), from an estimated log Kow of -1.00(6)and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Sucralose is not eliminated in wastewater treatment plants and was shown to be very persistent in surface waters(8), indicating that biodegradation is not an important environmental fate process in water(SRC).
ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), sucralose, which has an estimated vapor pressure of 3.2X10-14 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase sucralose may be removed from the air by wet or dry deposition(SRC). Sucralose does not contain chromophores that absorb at wavelengths >290 nm(4), and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).
/AQUATIC SPECIES/ .../The report presents sucralose/ bioaccumulation studies in the freshwater alga Pseudokirchneriella subcapitata, the crustacean Daphnia magna, and zebrafish (Danio rerio). The freshwater algae and the daphnid tests were performed using a 48-hr static exposure system, whereas the zebrafish test was performed using a 48-hr semi static exposure system followed by 48 hr flow-through of clean water for the depuration phase. All three studies were conducted with two exposure concentrations (10 and 100 mg/L), and the concentrations of sucralose in water and biota were verified by liquid chromatography/mass spectrometry. The studies showed that uptake of sucralose was assumed to achieve a steady state within the first 48 hr, and the bioconcentration factor at the assumed steady state (BCF(SS) ) was calculated to be less than 1 for algae and between 1.6 to 2.2 for the daphnids. The fish BCF(SS), assumed to occur between 24 to 48 hours, were calculated to be less than 1 for both concentrations tested. A first-order one-compartment (uptake phase) and a first-order two-compartment (elimination phase) model characterized the uptake and depuration kinetics in zebrafish (k(1)=0.027-0.038/hr and k(2)=0.206-0.222/hr, t(95)=13.5 to 14.6 hr, t(50)=3.1 to 3.3 hr, and BCF(kinetic)=0.4 to 0.9). .../Therefore,/ sucralose does not bioaccumulate in aquatic organisms from different tiers of the food web, and ... the BCF's obtained were considerably lower than the criteria set to identify persistent, bioaccumulative, and toxic substances (i.e., BCF < 2,000).
Using a structure estimation method based on molecular connectivity indices(1), the Koc of sucralose can be estimated to be 10(SRC). According to a classification scheme(2), this estimated Koc value suggests that sucralose is expected to have very high mobility in soil.
/HUMAN EXPOSURE STUDIES/ A total of .../26/ patients with glycosylated hemoglobin levels < 10% completed ... double-blind cross-over study. After an overnight fast, patients were administered opaque capsules containing either 1,000 mg sucralose or cellulose placebo, followed by a standardized 360-kcal liquid breakfast. Plasma glucose and serum C-peptide levels were measured over the next 4 hr. Regardless of the type of diabetes, areas under the curves for changes of plasma glucose and serum C-peptide levels after sucralose administration were not significantly different from those after placebo. During test meals with sucralose, one episode of symptomatic hypoglycemia occurred in ... three patients, but these episodes were not considered the result of sucralose administration. The present results support the conclusion that sucralose consumption does not adversely affect short-term blood glucose control in patients with diabetes.
/HUMAN EXPOSURE STUDIES/ Eight ... subjects (4 male and 4 female) first received ascending oral doses of TGS in doses of 0.0, 1.0, 2.5, 5.0 and 10.0 mg/kg at 48-hour intervals. This was followed by 7 days continuous administration of 2.0 mg/kg daily for the first three days and 5.0 mg/kg daily for the remaining four days. There were no adverse reactions or complaints throughout the study. No clinically significant changes were observed in temperature, pulse, blood pressure (supine or standing), respiratory rate and general conditions. Detailed hematological and biochemical studies were made before the study, then after 2.0 mg/kg/day and 5.0 mg/kg/day during the second phase. There were no abnormalities in any of the parameters measured. Electrocardiogram studies throughout showed no changes from the initial findings. Urinary examination showed no abnormalities, and an assessment of 24 hour urine volumes throughout the study detected no effects. Blood insulin levels measured one half hour after each dosage showed levels ranging from 4.038.0 milliunits/mL, which were within the fasting range. On Day 25 of the study, blood insulin levels were measured one half hour after 50 g standard sucrose. All showed the characteristic increase within the range 53-108 milliunits/mL.
/CASE REPORTS/ /The study/ report a patient with attacks of migraine consistently triggered by sucralose. She also suffers from menstrually related migraine that had been well-controlled for several months since she switched her contraceptive from fixed estrogen to triphasic contraceptive pills. Some attacks triggered by sucralose were preceded by aura, and she had never experienced migraine with aura before. Withdrawal of the compound was associated with complete resolution of the attacks. Single-blind exposure (vs. sugar) triggered the attacks, after an attack-free period.
AEROBIC: Sucralose is not eliminated in wastewater treatment plants located in the Canton of Zurich, Switzerland and was shown to be very persistent in surface waters. Incubation using activated sludge resulted in no degradation within 7 hours at 15 °C(1).
AEROBIC: Sucralose biodegradation in soil. Acclimation of 4-8 days was observed when using sucrose concentrations at 100 and 1000 mg/kg. Soil characteristics were as follows: Lima loam (pH 7.2; 7.8% organic matter); Kendala loam (pH 7.1; 7.1% organic matter); Erie silt loam (pH 4.9: 5.5% organic matter); Riverhead sandy loam (pH 7.2; 3.6% organic matter)(1). [Table#7886]
AEROBIC: Sucralose mineralization in surface water samples(1). [Table#7887]
AEROBIC: Sucralose mineralization in sediment samples(1).
ANAEROBIC: Sucralose was not mineralized in soil under anaerobic conditions(1).
An estimated BCF of three was calculated in fish for sucralose(SRC), using an estimated log Kow of -1.00(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC).
The Henry's Law constant for sucralose is estimated as 4.0X10-19 atm-cu m/mole(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that sucralose is expected to be essentially nonvolatile from water and moist soil surfaces(2). Sucralose is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.2X10-14 mm Hg(SRC), determined from a fragment constant method(3).
/LABORATORY ANIMALS: Acute Exposure/ Sucralose is a non-nutritive halogenated sucrose derivative that has been described by humans as tasting predominately sweet with little or no aftertaste. ... this study ... examined the preference for sucralose in adult male Sprague Dawley rats. A standard 24 hr two-bottle test was used to compare a wide range of sucralose concentrations (0.0003-10g/L; 0.8 uM-25 mM) with water. The rats did not prefer sucralose to water at low concentrations(0.0003 -0.3 g/L) and avoided sucralose at high concentrations (1-10g/L). Although there are many similarities in the taste preference of humans, mice, and rats, these results suggest that male rats do not prefer sucralose and avoid it at high concentrations.
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Dietary level of trichlorogalactosucrose 0, 10,000, 20,000, 40,000, and 80,000 ppm were fed to the animals /rats/ for 59 days. During this time, the health status, body weight, food and water consumption and urine and feces output were monitored daily with the exception of weeks 7 and 8. Mineral excretion as well as urinary free corticosterone levels were determined on pooled weekly samples from each animal. Mineral intake was calculated weekly and was based on mineral content in the diet and weekly food consumption for each group by sex. Dietary trichlorogalactosucrose had no effects on health status. There appeared to be a trend toward lower body weights in animals fed the higher dietary levels of trichlorogalactosucrose. At 9 weeks, body weights in the females fed 8% trichlorogalactosucrose in the diet were significantly lower than the corresponding controls. Water consumption was significantly increased during week 9 in males fed 2, 4, and 8% trichlorogalactosucrose in the diet. Food consumption was significantly decreased in females fed trichlorogalactosucrose at 1, 4, and 8% during the first week trichlorogalactosucrose was presented in the diet. Fecal output was significantly increased approximately 1.5-fold over control levels in the 4% animals during weeks 3-9 and approximately twofold over control levels in both sexes at the 8% level; and the dry/wet feces ratio was significantly decreased in both males and females during week 3, confirming that the increase in fecal weight was due to an increase in water content. There were no consistent dose-related effects on urine output, caloric efficiency, urinary free corticosterone levels, or the excretion of calcium, magnesium, zinc or copper. A transient decrease in fecal copper was seen in both males and females fed 4 and 8% dietary trichlorogalactosucrose during the second week, and an increase only in males in the ninth week. A not always significant or dose-related trend toward decreased urinary excretion of phosphorous was observed in both males and females throughout the study. Terminal body weights for females fed 4 and 8% trichlorogalactosucrose in the diet were significantly lower than the control terminal body weights. Wet cecum weights with contents were increased significantly in both males and females fed 4 and 8% trichlorogalactosucrose in the diet. No other tissue weights were significantly different from the corresponding controls. However, there was a dose-related trend toward decreased thymus weight in the females. Kidney calcium levels were unaffected as were serum free corticosterone levels and white blood cell counts.
Sucralose is a food additive permitted for direct addition to food for human consumption, as long as 1) the quantity of the substance added to food does not exceed the amount reasonably required to accomplish its intended physical, nutritive, or other technical effect in food, and 2) any substance intended for use in or on food is of appropriate food grade and is prepared and handled as a food ingredient.
After single intravenous doses of (14)C-trichlorogalactosucrose to dogs at a dose level of 2 mg/kg (5.8 uCi/kg) radioactivity was rapidly excreted mainly in the urine. Urinary excretion accounted for means of 29.3%, 63.9% and 74.1% of the dose during 3, 6 and 12 hours after dosing respectively, increasing to 80.9% of the dose after 5 days. Fecal excretion accounted for a mean of 10.4% dose after 24 hours, increasing to 11.9% dose after 5 days. Plasma radioactivity was maximal at 5 minutes after dosing (the first time of sampling, 8.46 ug equivalents/mL). Radioactivity in plasma declined in a multi-exponential fashion; concentrations decreased rapidly to a mean of 0.057 ug equivalents/ml at 12 hours after dosing but thereafter declined more slowly, and were still detectable in all animals at 120 hours after dosing (mean, 0.013 ug equivalents/ml). Consideration of whole-blood and plasma concentrations indicated that radioactivity was cleared more slowly from blood cells than from plasma.
(14)C-trichlorogalactosucrose (1 mg/kg; 100 uCi > 98% pure) was given orally dissolved in water to 8 normal, healthy male volunteers and blood, urine and feces collected for up to 5 days after the dose. The total recovery of (14)C-activity was 92.7% (range 87.8-99.2%) with most of the radioactivity 78.3% (range 69.4-89.6%) in the feces, and the remainder 14.4% (range 8.8-21.7%) in the urine. The plasma concentrations of (14)C-activity reached a peak at about 2 hr after the dose, with levels of (14)C equivalent to approximately 250 ng/mL of trichlorogalactosucrose. The plasma concentrations fell rapidly between 2 and 12 hr followed by a more gradual decrease until 72 hr by which time the levels of radioactivity were near or below the limit of accurate determination. The mean 'effective half-life' calculated on the basis of a mean residence time (MRT) of 18.8 hr gives a value of 13.0 hr.
Three male subjects given a single oral dose (1.11 mg/kg b.w., 0.3 uCi/kg) of trichlorogalactosucrose uniformly labelled with carbon-14 excreted an average of 13.5% of the radioactivity in urine and 82.1% in feces in 5 days. No (14)CO2 was detected in expired air collected during the initial 8 hours after dosing. Maximum levels of radioactivity in the blood occurred within 2-3 hours and in two of the subjects declined with a half-life of approximately 2.5 hours. Chromatographic examination of the 0-3 hours urines indicated the presence of only a single radioactive component.
After single oral doses of (14)C-trichlorogalactosucrose to non-pregnant and pregnant rabbits at a dose level of 10 mg/kg, radioactivity was excreted mainly in the feces. During 24 hours after dosing, a mean of 16.8% of the dose was excreted in the feces of non-pregnant animals, increasing to 31.8% during 48 hours and 54.7% during 120 hours. Excretion of radioactivity in the feces of pregnant rabbits was similar, with means of 27.8%, 43.0% and 65.2% of the dose excreted by this route during 24, 48 and 120 hours after dosing, respectively. Means of 5.3% and 4.2% dose were excreted in the feces of non-pregnant and pregnant rabbits respectively during 96-120 hours after dosing, indicating that excretion of radioactivity was not completed after 5 days, probably because of the coprophagic behavior of rabbits. During 24 hours, means of 8.3% and 8.6% of the dose were excreted in the urine of non-pregnant and pregnant rabbits, respectively. Mean totals of 22.3% (non-pregnant rabbits) and 21.5% (pregnant rabbits) of the dose was gradually excreted in the urine during 5 days after dosing. Radioactivity was still being excreted in the urine of rabbits (up to 2.9% dose) during 96-120 hours after dosing. Mean total recoveries of radioactivity from the urine and feces of non- pregnant and pregnant rabbits after 5 days accounted for 80.3% and 87.0% of the dose respectively. The dose not accounted for was presumably still to be excreted since a total of up to 8.4% of the dose was excreted during 96-120 hours after dosing. There were no notable differences in the absorption and excretion of single oral doses of (14)C-trichlorogalactosucrose between non-pregnant and pregnant rabbits.
For more Absorption, Distribution and Excretion (Complete) data for Sucralose (14 total), please visit the HSDB record page.
CIR ingredient: Sucralose
Chlorinated derivative of sucrose; Used as a non-nutritive sweetener; [Merck Index]
Flavor enhancer
Add sweetness with or without the extra calories ... /in/ beverages, baked goods, confections, table-top sugar, substitutes, many processed foods
Non-nutritive sweetener
The starting material for the synthesis of sucralose is sucrose. The production route commonly described blocks the three primary hydroxyl groups as trityl ethers, and transforms the secondary hydroxyl groups to acetates to yield 6,1',6'-tritrityl-2,3,4,3',4'- pentaacetylsucrose. By deblocking the primary hydroxyl groups, 2,3,4,3',4'-pentaacetylsucrose is obtained. Under appropriate conditions, this compound can be transformed to 2,3,6,3',4'- pentaacetylsucrose. Chlorination at the exposed hydroxyl groups gives 4,1',6'-trichloro-4,1',6'- tridesoxygalactosucrose on conversion of the glucose moiety to galactose. Removal of the acetate groups by hydrolysis yields sucralose.
Food additives
Food Additives -> SWEETENER -> JECFA Functional Classes
Food Additives -> SWEETENER -> JECFA Functional Classes
Chlorinated sucrose derivative with enhanced sweetness
Compared with dilute sucrose solution, sucralose is about 600 times sweeter. The sweetness is perceived with a slight delay and a lasting effect, similar to aspartame, and generally considered of good quality.
Solid sucralose is not fully stable, and slowly releases HCl, with discoloration. In contrast, aqueous solutions are highly stable, and it is marketed in this form.
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Groups of 15 male and 15 female CD rats received trichlorogalactosucrose in the diet at concentrations of 10,000, 25,000 or 50,000 ppm. A similarly constituted group of rats received diet alone without added trichlorogalactosucrose and acted as a control group. These animals were killed after four weeks of treatment. An additional six male and six female rats were assigned to each of the control and highest treatment (50,000 ppm) groups and were treated for eight weeks. The animals were originally designated to investigate the reversibility of any effects of treatment with trichlorogalactosucrose, but were used instead for a four-week extended treatment period. There were no deaths. Food and water consumption of treated rats were essentially unaffected by the administration of trichlorogalactosucrose. Reduced body weight gain was recorded for male rats receiving 25,000 ppm and male and female rats receiving 50,000 ppm of trichlorogalactosucrose, when compared with that of the control animals. Food utilization was less efficient in rats receiving 50,000 ppm, when compared with that of the control animals. Ophthalmoscopic examination during week 3 of treatment revealed no abnormality that could be ascribed to the administration of trichlorogalactosucrose. Hematological differences between treated and control rats were limited to a marginally lower number of lymphocytes in females receiving 50,000 ppm. No inter-group differences were evident in bone marrow smears after four or eight weeks of treatment. A dosage-related reduction in plasma alanine aminotransferase activity was recorded after four weeks of treatment in all treated groups of rats. This effect was not apparent after eight weeks of treatment. When compared with the controls, increased urinary calcium and magnesium excretion was recorded after three weeks of treatment in rats receiving 50,000 ppm of trichlorogalactosucrose. A similar trend was also apparent in females after seven weeks of treatment. Lower urinary volume was also recorded at both examinations for male rats receiving this dosage. A dosage-related increase in cecum weights was recorded for rats sacrificed after four weeks of treatment. A similar but less marked effect was recorded for rats killed after eight weeks. There was a trend towards a reduction in the weights of the spleen, thymus, adrenals and ovaries following treatment with 50,000 ppm trichlorogalactosucrose for either four or eight weeks. There were no macropathological observations for rats killed after four or eight weeks of treatment that could be associated with the administration of trichlorogalactosucrose. Treatment-related changes were observed microscopically in the cecum, liver, spleen and thymus. Goblet cell hyperplasia of the cecum and periacinar hepatocytic hypertrophy were present, in some of the males that received 25,000 or 50,000 ppm for four weeks. The hepatic effects were present after eight weeks in males and females that received 50,000 ppm. Lymphoid hypoplasia of the spleen and thymus was apparent after both four and eight weeks in males fed 50,000 ppm. The only effect in females was splenic lymphoid hypoplasia after eight weeks of treatment in those receiving 50,000 ppm. It was concluded that 10,000 ppm of trichlorogalactosucrose represents a minimum physiological effect level, 25,000 ppm represents a level of slight change and 50,000 ppm elicited a clear response to treatment. None of the observed effects was sufficiently marked, however, to cause any overt change in the general well-being of the animals.
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ The toxicity of sucralose .../was/ evaluated in acute and subchronic toxicity studies. Acute oral toxicity studies in male and female mice and male rats documented no deaths or treatment-related signs at doses of 16 g/kg for mice and 10 g/kg for rats. Sucralose was administered to male and female rats for 4 and 8 weeks at dietary concentrations of 1.0, 2.5 or 5.0%. Achieved dose ranges (mg/kg/day) for the respective dietary levels were 737-1287, 1865-3218 and 2794-6406. There were no toxicologically significant effects observed at the 1.0% or 2.5% dietary levels. However, decreases in food consumption, body weight gain and selected organ weights and ratios as well as splenic and thymic histopathologic changes occurred in rats administered 5.0% for 4 or 8 weeks. A gavage study wherein doses of 0, 750, 1500 or 3000 mg/kg/day were administered to male and female rats for 26 weeks investigated further the observations from the dietary study as well as general subchronic toxicity. The gavage study documented no sucralose-related toxicity. These results implicate the reduced palatability and digestibility of diets containing high concentrations of sucralose seen in the diet study as the cause for the decreased food consumption and other accompanying alterations. Dose selection for chronic toxicity studies in rats took into consideration the effect of high concentrations of sucralose on digestion and food consumption and the limitations that would be imposed on subsequent studies. These studies establish that sucralose is non-toxic in rodents following acute oral administration. The rat no-observed-adverse-effect level ranged between 2.5 and 5.0% following subchronic dietary administration.
For more Non-Human Toxicity Excerpts (Complete) data for Sucralose (17 total), please visit the HSDB record page.